This $1,054,933 Department of Defense Project Grant awarded to Purdue University under the Military Medical Research and Development program (CFDA 12.420) will fund research to target NNMT (nicotinamide N-methyltransferase) in order to inhibit obesity-associated breast cancer development and progression. The 3-year award period runs from September 1, 2023 to August 31, 2026. As the prime awardee, Purdue University will conduct the biomedical research to investigate medical solutions for this health issue that impacts Service Members and the broader American public. The grant aims to transform healthcare through innovative and impactful research.
Generated 6/11/24, 12:32 PM